"Harmful" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
Some believe that ACE-I/ARB use is harmful in treating SARS-CoV-2 infections because they increase the expression of ACE2, allowing the virus more opportunity to enter host cells.
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
"Beneficial" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
Chronic ACE-I/ARB Use Is Associated with Acute Kidney Injury (AKI) in Severe COVID-19 Patients
Rationale in Using ACE Inhibitors (ACE-Is) to Treat or Prevent COVID-19
Controversy of Using ACE Inhibitors (ACE-Is) for Blood Pressure Management in COVID-19
Related
"Beneficial" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
Chronic ACE-I/ARB Use Is Associated with Acute Kidney Injury (AKI) in Severe COVID-19 Patients
Rationale in Using ACE Inhibitors (ACE-Is) to Treat or Prevent COVID-19
Controversy of Using ACE Inhibitors (ACE-Is) for Blood Pressure Management in COVID-19